The company said the appointment will allow it to focus on advancing Caldera’s position in the women’s health sector with M&A activity during rapid expansion.
Pitstick began his career at Ernst & Young managing a global client base and contributing to several IPOs. Most recently, he was CFO of Dyve Biosciences. He has also served as CFO of Seven Lakes Technologies and Conversant.
As CFO of Caldera Medical, Pitstick’s experience in leading mergers and acquisitions will be pivotal, the company said. His experience includes overseeing transactions exceeding $3 billion and has successfully raised over $1 billion in financing. Caldera has ambitious expansion plans, including strategic acuqisionts to enhance the company’s portfolio and market presence, according to the company.
Caldera Medical develops, manufactures and markets surgical products for treating stress urinary incontinence, pelvic organ prolapse, polyps and fibroids.